siRNA, Anti-Human ADRB2, LNA(CAT#: SIRGT04103WQ-LNA)

The product SIRGT04103WQ-LNA is a type of small interfering RNA (siRNA) that targets ADRB2 gene and regulates the expression of gene. The siRNA interferes with the expression of ADRB2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000024.5
Alternative Names ADRB2R; ADRBR; B2AR; BAR; BETA2AR
Related Diseases Parkinson's Disease, Obesity, Type 2 diabetes, Cardiovascular disease
Purification HPLC
Target Gene
Gene ID 154
Uniprot ID P07550

Related Products